STAT3-survivin signaling mediates a poor response to radiotherapy in HER2-positive breast cancers

Although radiotherapy resistance is associated with locoregional recurrence and distant metastasis in breast cancers, clinically relevant molecular markers and critical signaling pathways of radioresistant breast cancer are yet to be defined. Herein, we show that HER2-STAT3-survivin regulation is as...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Jae-Sung, Kim, Hyun-Ah, Seong, Min-Ki, Seol, Hyesil, Oh, Jeong Su, Kim, Eun-Kyu, Chang, Jong Wook, Hwang, Sang-Gu, Noh, Woo Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872768/
https://www.ncbi.nlm.nih.gov/pubmed/26755645
http://dx.doi.org/10.18632/oncotarget.6855

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872768/
https://www.ncbi.nlm.nih.gov/pubmed/26755645
http://dx.doi.org/10.18632/oncotarget.6855

Ejemplares similares